Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates.

Journal: La Clinica terapeutica
PMID: 26794819

Abstract

OBJECTIVES: The aim of the current study was to analyze the susceptibility of gram-positive and -negative clinical isolates to a novel des-F(6)-quinolone (nemonoxacin) and other selected antimicrobial agents.

Authors

  • Z X Li
    Department of Respiratory Diseases, Second Artillery General Hospital, Beijing 100088, People's Republic of China.
  • Y N Liu
    Departments of Respiratory Diseases, People's Liberation Army General Hospital, Beijing 100853, People's Republic of China.
  • R Wang
    School of Forensic Medicine, Kunming Medical University, Kunming 650500, China.
  • A M Li
    Departments of Respiratory Diseases, People's Liberation Army General Hospital, Beijing 100853, People's Republic of China.

Keywords

External Resources

Popular Topics
Recent Journals